Growth Hormone Secretagogues
Ipamorelin & Tesamorelin Research Overview
Growth hormone secretagogues are research compounds that engage the endogenous pathways governing pulsatile GH release. Tesamorelin and Ipamorelin act through distinct but complementary mechanisms within this axis.
- Published
- January 15, 2025
- Last Reviewed
- November 1, 2025
- How GHRH and ghrelin pathways drive GH release
- Why pulsatility matters in GH research
- Distinctions between Tesamorelin and Ipamorelin
- Downstream signaling pathways examined in the published literature
- Primary Category
- Performance
- Relevant Compounds
- Tesamorelin
- Ipamorelin
- Research Focus
- GH-axis signaling
- Pulsatile release
- Downstream IGF-1 pathway literature
Scientific Overview
Endogenous growth hormone is released by the anterior pituitary in a pulsatile pattern shaped by GHRH (growth hormone releasing hormone) and ghrelin signaling. Research compounds in this class engage either the GHRH receptor or the ghrelin receptor to study their effect on this physiological rhythm.
Pulsatility — not magnitude alone — defines how GH research is interpreted.
Key Mechanisms
GHRH pathway
Tesamorelin is a GHRH analog studied for its effect on the hypothalamic-pituitary axis. GHRH receptor activation supports the natural amplitude and timing of GH pulses.
Ghrelin receptor pathway
Ipamorelin is a selective ghrelin receptor agonist studied for its ability to engage GH-releasing pathways with limited effect on cortisol or prolactin in published research models.
Pulsatile release
The endogenous GH rhythm differs meaningfully from sustained exogenous administration. Secretagogue research focuses on preserving physiological pulsatility.
Downstream literature areas
Published literature characterizes downstream signaling along the GH/IGF-1 axis, including effects on lean tissue compartments, adipose distribution, sleep-associated GH pulses, and connective tissue remodeling as areas of ongoing scientific investigation.
KEY TAKEAWAYS
- Secretagogues engage endogenous GH pathways rather than replacing them.
- GHRH and ghrelin receptors are complementary mechanisms of study.
- Pulsatile release defines the physiological rhythm of GH.
- Circadian timing and metabolic context inform research design.
Areas of Ongoing Research
- Endocrine signaling literature following repeated secretagogue exposure in preclinical models.
- Interactions between GHRH and ghrelin receptor pathways.
- Literature on sleep-associated GH pulses and circadian signaling.
Research Considerations
- The endocrine system is highly interconnected; isolated receptor study has interpretive limits.
- Pulsatile release patterns described in the literature are sensitive to timing, nutrition, and circadian factors.
- Comparative literature across secretagogues continues to expand.
RELATED PRODUCTS
RELATED COLLECTIONS
RELATED RESEARCH
The information provided within the VELOR Research Library is intended solely for educational and informational purposes. Content summarizes published scientific literature and ongoing areas of research. Products referenced on this website are supplied exclusively for laboratory and research applications. Researchers are responsible for compliance with all applicable laws, regulations, and institutional policies.